Breast cancer patients with obesity who were assigned to adjuvant chemotherapy had a higher risk of BCR compared with breast cancer patients with a healthy weight (HRadj = 2.06 [95%CI 1.08–4.31]). The gene discussed is BCR; the disease is obesity due to melanocortin 4 receptor deficiency.